Pharmalink retains full commercial rights to its product candidates in all territories and plans to commercialise them directly in selected territories and establish licensing and/or distribution agreements with pharmaceutical partners elsewhere.

In addition to being based on high-quality science and development to high international standards, Pharmalink's product candidates are characterised by the rigour with which we define and maximise commercial potential and provide proof-of-value to our out-licensing partners.

The Company will also assess opportunities for clinical stage and near-to-market niche or hospital care products where its development and marketing expertise can be leveraged.

For further information or to discuss new opportunities, please contact: